Lipid metabolism displays phenotype-specific regulatory patterns across distinct clinical presentations, with differential pathway involvement and functional enrichment. Key lipid species such as TG, PC, and Cer may serve as potential subtype biomarkers or therapeutic targets, offering novel insights into the early identification and precision management of metabolic disturbances in children.